1 |
조보연, 고창순. 한국에서 그레이브스병의 진단과 치 료 현황. -설문조사 분석 및 유럽, 미국, 일본과의 비 교. 대한내분비학회지 1992;7:216-27
|
2 |
Hall P, Boice JD Jr, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Mattsson A, Tennvall J, et al. Leukaemia incidence after iodine-131 exposure. Lancet 1992;340:1-4
PUBMED
|
3 |
Lind P. Strategies of radioiodine therapy for Graves' disease. Eur J Nucl Med 2002;29:S453-7
DOI
ScienceOn
|
4 |
Wang CY, Chang TJ, Chang TC, Hsiao YL, Chen MH, Huang SH. Thyroidectomy or radioiodine? The value of ultrasonography and cytology in the assessment of nodular lesions in Graves' hyperthyroidism. Am Surg 2001;67:721-6
PUBMED
|
5 |
Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism-- prognostic factors for outcome. J Clin Endocrinol Metab 2001;86:3611-7
DOI
ScienceOn
|
6 |
Jarlov AE, Hegedus L, Kristensen LO, Nygaard B, Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clin Endocrinol 1995;43:325-9
|
7 |
Kok SW, Smit JW, de Craen AJ, Goslings BM, van Eck-Smit BL, Romijn JA: Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study. Nucl Med Commun 2000;21:1071-8
DOI
ScienceOn
|
8 |
Moka D, Voth E, Schicha H. Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy. Nuklearmedizin 1997;36:87-92
PUBMED
|
9 |
Moka D, Dietlein M, Schicha H. Radioiodine therapy and thyrostatic drugs and iodine. Eur J Nucl Med 2002;29:S486-91
DOI
ScienceOn
|
10 |
Bartalena L, Pinchera A, Marcocci C: Management of Graves' ophthalmopathy. reality and perspectives. Endocrine Reviews 2000;21:168-99
DOI
ScienceOn
|
11 |
DeGroot LJ. Radioiodine and the immune system. Thyroid 1997;7:259-64
DOI
PUBMED
ScienceOn
|
12 |
Hennemann G, Krenning EP, Sankaranarayanan K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet 1986;1:1369-72
PUBMED
|
13 |
Weiss M, Gorges R, Hirsch F, Bader J, Tatsch K, Hahn K. Immunogenic hyperthyroidism following iodine-131 therapy of non-immunogenic, autonomous thyroid nodules: results of a multicenter evaluation. Med Klin 1999;94:239-43
DOI
|
14 |
배진호, 정신영, 안병철, 이재태, 이규보. I-131 치료 에 의한 Graves병의 악화. 대한핵의학회지 2003;5: 68p
|
15 |
Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A. Cigarette smoking and treatment outcome in Graves opthalmopathy. Ann Intern Med 1998;129:632-5
DOI
PUBMED
ScienceOn
|
16 |
Bonnema SJ, Bartalena L, Toft AD, Hegedus L. Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. Eur J Endocrinol 2002;147:1-11
DOI
ScienceOn
|
17 |
Dale J, Daykin J, Holder R, Sheppard MC, Franklyn JA. Weight gain following treatment of hyperthyroidism. Clin Endocrinol 2001;55:233-9
DOI
ScienceOn
|
18 |
Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine(I) for hyperthyroidism. N Engl J Med 1975;292:167-71
DOI
PUBMED
ScienceOn
|
19 |
Becker DV, Sawin CT. Radioiodine and thyroid disease: the beginning. Semin Nucl Med 1996;26 :155-64
DOI
ScienceOn
|
20 |
Howarth D, Epstein M, Lan L, Tan P, Booker J. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Eur J Nucl Med 2001;28:1489-95
DOI
ScienceOn
|
21 |
Ron E, Doody MM, Becker DV. Brill AB, Curtis RE, Goldman MB, Benjamin SH, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice Jr JD. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998;280:347-55
DOI
PUBMED
ScienceOn
|
22 |
Tallstedt L, Lundell G, Taube A. Graves' ophthalmopathy and tobacco smoking. Acta Endocrinol 1993;129:147-50
|
23 |
Pinchera A, Bartalena L, Marcocci C. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but.. J Clin Endocrinol Metab 1995;80:342-5
|
24 |
Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol 1991;34:71-6
DOI
|
25 |
Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990;70:1518-24
DOI
PUBMED
|
26 |
Bogazzi F, Bartalena L, Brogioni S, Scarello G, Burelli A, Campomori A, Manetti L, Rossi G, Pinchera A, Martino E. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab 1999;84:499-503
DOI
ScienceOn
|
27 |
이광우, 손현식, 한제호, 유순집, 윤건호, 강무일, 홍 관수, 차봉연, 손호영, 강성구. 그레이브스 갑상선기 능항진증 환자의 방사성옥소 치료에 있어서 10 mCi 투여군과 일반적 계산용량 투여군의 3년간 추적결과. 대한내분비학회지 1992;7;358-63
|
28 |
Reinhardt MJ, Brink I, Joe AY, Von Mallek D, Ezziddin S, Palmedo H, Krause TM. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur J Nucl Med 2002;29:1118-24
DOI
ScienceOn
|
29 |
Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, Buell U. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 1999;84:1229-33
DOI
ScienceOn
|
30 |
Marcocci C, Bruno-Bossio G, Manetti L, Tanda ML, Miccoli P, Iacconi P, Bartolomei MP, Nardi M, Pinchera A, Bartalena L. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin Endocrinol 1999;51:503-8
DOI
ScienceOn
|
31 |
Berg GE, Michanek AM, Holmberg EC, Fink M. Iodine-131 treatment of hyperthyroidism. significance of effective half-life measurements. J Nucl Med 1996;37:228-32
PUBMED
|
32 |
Gorman CA. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy. J Clin Endocrinol Metab 1995;80:340-2
DOI
PUBMED
|
33 |
Nygaard B, Faber J, Veje A, Hegedus L, Hanssen JM. Relation between thyroid stimulating immunoglobulin and transient thyrotoxicosis in 4 patients treated with I-131 for non-toxic multinodular goiter. Eur J Endocrinol 1994;130;7
|
34 |
Kaplan MM, Meier DA, Dwaorkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrionol Metab Clin North Am 1998;27:205-22
DOI
ScienceOn
|
35 |
Bal CS, Kumar A, Pandey RM. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid 2002;12:399-405
DOI
ScienceOn
|
36 |
Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, Taube A. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med 1992;326:1733-8
DOI
PUBMED
ScienceOn
|
37 |
Wesche MF, Tiel-van Buul MM, Smits NJ, Wiersinga WM. Ultrasonographic versus scintigraphic measurement of thyroid volume in patients referred for I therapy. Nucl Med Commun 1998;19:341-6
DOI
PUBMED
ScienceOn
|
38 |
Reynolds LR, Kotchen TA. Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease. Arch Intern Med 1979;139:651-3
DOI
ScienceOn
|
39 |
Weetman AP, Harrison BJ. Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy? J Endocrinol Invest 1998;21:472-5
|
40 |
Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003;88:978-83
DOI
ScienceOn
|
41 |
Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998;338:73-8
DOI
ScienceOn
|
42 |
Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 1974;38:976-98
DOI
PUBMED
|
43 |
Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism. one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 2001; 86:3488-93
DOI
ScienceOn
|
44 |
Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol 1997;47:425-30
DOI
ScienceOn
|
45 |
Tepmongkol S: Enhancement of radioiodine uptake in hyperthyroidism with hydrochlorothiazide. a prospective randomised control study. Eur J Nucl Med 2002;29:1307-10
DOI
ScienceOn
|
46 |
Stoffer SS, Hamburger JI. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med 1976;17:146-9
PUBMED
|
47 |
Alexander EK, Larsen PR. High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2002;87: 1073-7
DOI
ScienceOn
|
48 |
Graham GD, Burman KD. Radioiodine treatment of Graves' disease. An assessment of its potential risks. Ann Intern Med 1986;105:900-5
DOI
PUBMED
ScienceOn
|
49 |
Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Saaf M, Hamberger B. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine-A prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab 1996;81:2986-93
|
50 |
Bonnema SJ, Bartalena L, Toft AD, Hegedus L. Controversies in radioiodine therapy. relation to opthalmopathy, the possible redioprotective effect of antithyroid drugs, and use in large goitres. Eur J Endocrionol 2002;147:1-11
DOI
ScienceOn
|
51 |
Vestergaard P, Rejnmark L, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Laurberg P, Mosekilde L. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 2002;12:69-75
DOI
ScienceOn
|
52 |
Hayek A, Chapman EM, Crawford JD. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N Engl J Med 1970;283:949-53
DOI
PUBMED
ScienceOn
|
53 |
Gittoes NJ, Franklyn JA. Hyperthyroidism. Current treatment guidelines. Drugs 1998;55:543-53
DOI
ScienceOn
|
54 |
Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998;83: 685-7
DOI
ScienceOn
|
55 |
Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 1990;150:1098-101
DOI
ScienceOn
|
56 |
Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves ' hyperthyroidism. J Clin Endocrinol Metab 2000;85:1038-42
DOI
ScienceOn
|
57 |
Bae SK. Radioiodine therapy of thyroid disease. Korean J Nucl Med 2001;35:P11-8
|
58 |
Nordyke RA, Gilbert FI Jr. Optimal I-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991;32;411-6
|
59 |
Tallstedt L, Lundell G, Blomgren H, Bring J. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 1994;130: 494-7
|
60 |
Tuttle RM, Patience T, Budd S. Treatment with propylthiouracil before radioactive iodine therapy is associated with higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 1995;5:243-7
DOI
ScienceOn
|
61 |
Kalinyak JE, McDougall IR. Editorial. How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab, 2003;88:975-7
|
62 |
Rini JN, Vallabhajosula S, Zanzonico P, Hurley JR, Becker DV, Goldsmith SJ. Thyroid uptake of liquid versus capsule I tracers in hyperthyroid patients treated with liquid I. Thyroid 1999;9:347-52
DOI
ScienceOn
|
63 |
Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994;330:1731-8
DOI
PUBMED
ScienceOn
|
64 |
Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35
DOI
ScienceOn
|
65 |
Meier DA, Brill DR, Becker DV, Clarke S, Silberstein EB, Royal HD, Balon HR. Procedure guideline for therapy of thyroid disease with iodine-131. J Nucl Med 2002;43:856-61
PUBMED
|
66 |
Willemsen UF, Knesewitsch P, Kreisig T, Pickardt CR, Kirsch CM. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease. Eur J Nucl Med 199;20:1051-5
|